Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Trading Statement

6 Jan 2010 07:00

RNS Number : 0818F
Tarsus Group PLC
06 January 2010
 



6 January 2010

Tarsus Group plc

Trading Update

Tarsus Group plc ('Tarsus' or 'the Group'), the international business-to-business media group, expects full year 2009 adjusted pre-tax profits to be in line with the Board's expectations.

Our strategy has been to continue to increase the Group's focus on its emerging markets division. These operations contributed approximately 33% of Group revenues in 2009, with management today announcing that it expects this proportion to increase to around 50% by 2013.

Group like-for-like revenue growth for the year ended 31 December 2009 has seen an increase of approximately 11% (1% excluding any benefit from currency movements). Like-for-like exhibition volumes (net square metres sold) were slightly up and encouragingly, total attendances were up 7% - ahead of our expectations.

Recent Trading

Trading since our last Interim Management Statement (IMS) issued on 19 November is set out below.

In summary, the emerging markets continued to perform well, while trading in Europe has remained challenging. We are also pleased to see early signs of recovery in the US market.

Emerging Markets

The second edition of the Dubai Airshow under our ownership took place in November and delivered revenues 19% ahead of the equivalent event in 2007. Attendance at this business-to-business exhibition, the Group's largest, was up an exceptional 18%. Re-bookings for the 2011 event are substantially ahead of the previous cycle.

Our strategy of increased focus on emerging markets was validated by the outstanding performance of Labelexpo Asia, with revenues up 46% and attendance up 19%. In volume terms, Labelexpo Asia is now our sixth largest exhibition.

We are continuing to build and deepen our Chinese business and have now set up a subsidiary company - wholly owned foreign enterprise (WOFE) - in Shanghai.

Europe 

The French business has performed broadly in line with our reduced expectations at the interim stage with full year revenues declining 12% compared with 2008Visitor attendance was up approximately 3%.

US

Against a difficult economic background our Medical division saw total revenues fall 7% in 2009 primarily reflecting a change in the mix towards higher margin education and training streams. Encouragingly, revenues for the Las Vegas event in December were unchanged on 2008

 

Outlook for 2010

Within each two-year cycle, odd years are by far the larger in profit terms for the Group as they contain the Dubai Airshow, as well as both Labelexpo Europe and Labelexpo Asia, replaced in even years by Labelexpo Americas

The Group's large events have continued to perform extremely well with smaller products, in line with the rest of the industry, being impacted by difficult market conditions.

There are two significant events in the first quarter of 2010 - the Off-Price Show in Las Vegas where current indications are that the exhibition will produce revenues comfortably ahead of the equivalent event in 2009; and the Mod'amont fashion accessories exhibition in Paris which is tracking a little behind where it was at a similar stage last year.

Bookings for the small Dubai exhibitions scheduled for the first quarter of 2010 are tracking slightly ahead of their previous editions.

During the last few years the Group's management has been focused on developing a portfolio of events that is diverse by both industry and geography in order to ensure that Tarsus is resilient throughout the economic cycle. This strategy, combined with a focus on market-leading events with an increasing bias towards emerging markets, leaves the Group well positioned as economic growth picks up. 

 

Tarsus Group plc:

Douglas Emslie, Group Managing Director 020 8846 2700

Ashley Milton, Group Finance Director 020 8846 2700

Media:

Madano Partnership 

Matthew Moth 020 7593 4000

Investors/Analysts:

IRfocus

Neville Harris 020 7593 4015

Scott Harris

Stephen Scott, Jeremy Wiseman 020 7653 0030

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVABRRVAARAR
Date   Source Headline
12th Jan 20187:00 amRNSTrading Update & launch of next phase of strategy
29th Dec 201710:03 amRNSTotal Voting Rights
13th Dec 20173:22 pmRNSScrip Dividend Circular (the "Circular")
5th Dec 201711:45 amRNSHolding(s) in Company
30th Nov 201710:33 amRNSTotal Voting Rights and Capital
21st Nov 20177:00 amRNSCapital Markets Seminar and Trading Update
14th Nov 20177:00 amRNSSite visit to Dubai Airshow
9th Nov 201710:41 amRNSBlock Listing Six Monthly Return
2nd Nov 20177:00 amRNSChange of Advisers
12th Oct 20177:00 amRNSTrading Statement
26th Sep 20177:00 amRNSAnalyst and Investor Site Visit
22nd Sep 20173:55 pmRNSHolding(s) in Company
12th Sep 20177:00 amRNSExpansion of Mexican Joint Venture
6th Sep 201711:38 amRNSBlock Listing Six Monthly Return
31st Aug 20179:31 amRNSTotal Voting Rights
29th Aug 20173:31 pmRNSDirector/PDMR Shareholding
16th Aug 20174:07 pmRNSHalf-year Report
2nd Aug 20171:38 pmRNSDirector/PDMR Shareholding
31st Jul 20172:42 pmRNSTotal Voting Rights
27th Jul 20175:05 pmRNSDirector/PDMR Shareholding
26th Jul 20177:00 amRNSHalf-year Report
11th Jul 201712:42 pmRNSApplication for Admission
30th Jun 20174:09 pmRNSTotal Voting Rights
21st Jun 201712:13 pmRNSResult of AGM
5th Jun 201711:24 amRNSScrip Dividend Circular
31st May 201710:09 amRNSTotal Voting Rights
19th May 20171:42 pmRNSNotice of AGM
18th May 201712:05 pmRNSHolding(s) in Company
17th May 20177:00 amRNSTrading Update
9th May 20172:45 pmRNSBlock Listing Six Monthly Return
28th Apr 201711:05 amRNSTotal Voting Rights
4th Apr 20175:17 pmRNSHolding(s) in Company
4th Apr 20175:16 pmRNSDirector/PDMR Shareholding
31st Mar 201710:37 amRNSTotal Voting Rights
30th Mar 20176:10 pmRNSDirector/PDMR Shareholding
17th Mar 20172:01 pmRNS2016 Annual Report
16th Mar 20172:29 pmRNSDirector/PDMR Shareholding
15th Mar 20178:41 amRNSHolding(s) in Company
6th Mar 20175:45 pmRNSDirector/PDMR Shareholding
6th Mar 20175:44 pmRNSDirector/PDMR Shareholding
1st Mar 20174:04 pmRNSApplication for Block Listing
1st Mar 20177:00 amRNSFinal Results
8th Feb 201712:19 pmRNSDirector Declaration
1st Feb 201712:02 pmRNSTotal Voting Rights
25th Jan 20177:00 amRNSCompletion of acquisition
17th Jan 201711:14 amRNSApplication for Admission
10th Jan 20177:00 amRNSYear-end Trading Update
30th Dec 20169:03 amRNSTotal Voting Rights
22nd Dec 20167:12 amRNSAcquisition of Hometex
14th Dec 20163:26 pmRNSScript Dividend Circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.